Evaluation of Fosmidomycin and Piperaquine in the Treatment of Acute Falciparum Malaria
Phase 2
- Conditions
- Oral Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria
- Interventions
- Drug: Fosmidomycin-Piperaquine
- First Posted Date
- 2014-07-24
- Last Posted Date
- 2015-06-15
- Lead Sponsor
- Jomaa Pharma GmbH
- Target Recruit Count
- 100
- Registration Number
- NCT02198807
Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated P.Falciparum Malaria in Children
- First Posted Date
- 2011-11-03
- Last Posted Date
- 2011-11-03
- Lead Sponsor
- Jomaa Pharma GmbH
- Target Recruit Count
- 52
- Registration Number
- NCT01464138
- Locations
- 🇲🇿
Centro de Investigacao em Saude da Manhica, Maputo, Mozambique
Fosmidomycin and Azithromycin for Acute Uncomplicated Plasmodium Falciparum Malaria (P. Malaria) in Adults
- First Posted Date
- 2011-11-03
- Last Posted Date
- 2011-11-03
- Lead Sponsor
- Jomaa Pharma GmbH
- Target Recruit Count
- 43
- Registration Number
- NCT01464125
- Locations
- 🇹ðŸ‡
Mahidol University, Bangkok, Thailand
Fosmidomycin With Clindamycin or With Clindamycin Plus Artesunate
- First Posted Date
- 2009-10-27
- Last Posted Date
- 2011-09-27
- Lead Sponsor
- Jomaa Pharma GmbH
- Target Recruit Count
- 40
- Registration Number
- NCT01002183
- Locations
- 🇹ðŸ‡
Mahidol University, Bangkok, Thailand
© Copyright 2025. All Rights Reserved by MedPath